Sangamo Therapeutics (SGMO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to -$14.4 million.
- Sangamo Therapeutics' Other Gross PP&E Adjustments rose 1878.87% to -$14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.4 million, marking a year-over-year increase of 1878.87%. This contributed to the annual value of $36.8 million for FY2024, which is 1982.33% down from last year.
- As of Q3 2025, Sangamo Therapeutics' Other Gross PP&E Adjustments stood at -$14.4 million, which was up 1878.87% from -$15.1 million recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Other Gross PP&E Adjustments registered a high of $45.9 million during Q4 2023, and its lowest value of -$70.9 million during Q1 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$20.9 million (2024), whereas its average is -$27.6 million.
- As far as peak fluctuations go, Sangamo Therapeutics' Other Gross PP&E Adjustments surged by 101347.77% in 2022, and later plummeted by 1982.33% in 2024.
- Over the past 5 years, Sangamo Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$3.3 million in 2021, then soared by 1013.48% to $30.4 million in 2022, then surged by 51.32% to $45.9 million in 2023, then dropped by 19.82% to $36.8 million in 2024, then tumbled by 139.17% to -$14.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$14.4 million for Q3 2025, versus -$15.1 million for Q2 2025 and -$16.0 million for Q1 2025.